Health Medical Breakthroughs Treatment

Leukemia Lymphoma Treatment Research Shows Promise: New drug cocktail unlocks potential of new Leukaemia treatment

Posted on Posted in Cancer News, Leukemia News, Lymphoma News

(SOURCE: UNIVERSITY OF MANCHESTER) – A new combination of drugs, tested by University of Manchester scientists, has significantly enhanced the survival of laboratory mice with lymphoma. According to the team, the effect of Obinutuzumab – a first-line treatment for non-Hodgkin lymphoma and leukaemia – is significantly enhanced when combined with drugs that stimulate the immune system. […]

Health Medical Breakthroughs Treatment

Lymphoma Treatment News: Immune Cell Therapy Shows Promising Results for Lymphoma Patients, says Moffitt Researchers

Posted on Posted in Cancer News, Lymphoma News

(SOURCE: H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE) –  Lymphoma is the most common blood cancer. The disease occurs when immune cells called lymphocytes multiply uncontrollably. Cancerous lymphocytes can travel throughout the body and form lymph node tumors. The body has two types of lymphocytes that can develop into lymphoma – B cells and T […]

Health Medical Breakthroughs Treatment

Hodgkin’s Lymphoma Reasearch News: NIAID Research Aids Discovery of Genetic Immune Disorder

Posted on Posted in Epstein-Barr Virus News, Lymphoma News

(SOURCE: NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES) – Immune Molecule Deficiency Increases Patients’ Risk of Epstein-Barr Virus and EBV-Related Cancer. Investigators at the National Institutes of Health (NIH) and international colleagues have identified a genetic immune disorder characterized by increased susceptibility and poor immune control of Epstein-Barr virus (EBV) and, in some cases, an EBV-associated cancer […]

Health Medical Breakthroughs Treatment

Lymphoma Testing News: Mayo Clinic first in U.S. to offer lymphoma genomic diagnostic test for patients

Posted on Posted in Cancer News, Lymphoma News

(SOURCE: MAYO CLINIC) – Mayo Clinic has created a genetic test to help guide diagnosis and treatment of patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin’s lymphoma. The Lymph2Cx test helps determine where the lymphoma started, assigning “cell-of-origin” groups using a 20-gene expression-based assay. It is the first test to go into […]

Health Medical Breakthroughs Treatment

Lymphoma Treatment Research News: Immunotherapy agent yields full and partial remissions in patients with aggressive non-Hodgkin lymphomas, study finds

Posted on Posted in Cancer News, Lymphoma News

(SOURCE: DANA-FARBER CANCER INSTITUTE) – An immunotherapy drug able to induce lasting remissions in classical Hodgkin lymphoma may be equally effective in patients with either of two rare, aggressive forms of non-Hodgkin lymphoma, results from a small case series indicate. Dana-Farber Cancer Institute investigators who treated the patients will report their findings at the 58th annual meeting […]

Health Medical Breakthroughs Treatment

Lymphoma Research News: Mutations in lymphoma patients undergoing transplants raise risk of second cancers

Posted on Posted in Cancer News, Lymphoma News

(SOURCE: DANA-FARBER CANCER INSTITUTE) – A significant percentage of lymphoma patients undergoing transplants with their own blood stem cells carry acquired genetic mutations that increase their risks of developing second hematologic cancers and dying from other causes, according to a study from Dana-Farber Cancer Institute. The mutations were found in about 30 percent of 401 patients with […]

Health Medical Breakthroughs Treatment

Lymphoma Treatment Research News: First Multicenter Trial Finds CAR T-Cell Immunotherapy Effective, Feasible for Hard-to-Treat Lymphoma

Posted on Posted in Cancer News, Lymphoma News

(SOURCE: AMERICAN SOCIETY OF HEMATOLOGY) Interim analysis shows nearly six-fold higher rate of complete remission for refractory non-Hodgkin lymphoma with KTE-C19 compared to historical data. An abstract presented during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego demonstrates that chimeric antigen receptor (CAR) T-cell therapy is a promising option for […]

Health Medical Breakthroughs Treatment

Essential Amino Acid Found to Play Key Role in Creation of Blood Stem Cells

Posted on Posted in Cancer News, Leukemia News, Lymphoma News, Multiple Myeloma

(Scientific American) According to an article recently published in Scientific American, a team of researchers from California and Japan has found that an essential amino acid plays a crucial role in the creation of blood stem cells. This type of discovery the scientists say could offer a potential alternative to chemotherapy and radiation in treating […]

Health Medical Breakthroughs Treatment

Opdivo Recommended by EMA Panel for Treatment of Classical Hodgkin’s Lymphoma

Posted on Posted in Cancer News, Lymphoma News

(Lymphona News Today) According to an article recently published in Lymphoma News Today, The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended that Opdivo (nivolumab) be approved for the treatment of classical Hodgkin’s lymphoma (cHL) in patients who relapsed or progressed after receiving an autologous stem cell transplant (ASCT) and Adectris (brentuximab vedotin) treatment.

Health Medical Breakthroughs Treatment

Hodgkin’s Lymphoma Survivors Affected by Lingering Fatigue

Posted on Posted in Cancer News, Lymphoma News

(US National Library of Medicine) According to a recent study published in The Lancet Oncology, patients with Hodgkin’s lymphoma might have persistent fatigue even years after treatment. However, knowledge of the development of fatigue persisting long after completion of treatment is limited. The research study involved a detailed analysis of fatigue in first-line clinical trials for […]